However, blood test endpoints, including plasma D-dimer, CEA, cancer antigen (CA) 125 levels, platelet (PLT), platelet to lymphocyte ratio (PLR), and platelet to neutrophil ratio (PNR) were significantly different between somatic cancer-related CVST group and CG. The gene discussed is CEACAM5; the disease is cancer.